FindTrial
Sign In

DNK-651-3

A Phase II Study to Assess the Immunogenicity and Safety of DNK-651 in Japanese over 13 years old.

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080223664
Enrollment
500
Registered
2017-09-29
Start date
2017-09-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of influenza infection

Interventions

investigational material(s) Generic name etc : DNK-651 INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : intradermal

Sponsors

DENKA SEIKEN CO.,LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Japanese over 13 years old

Exclusion criteria

Exclusion criteria:

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026